A spinal cord injury is devastating, changing a person’s life in a heartbeat. In the past there was little that doctors could do other than offer pain relief and physical therapy to try and regain as much muscle function as possible. That’s why the latest results from the CIRM-supported Asterias Biotherapeutics spinal cord injury trial … Continue reading Stem cell treatment for spinal cord injury offers improved chance of independent life for patients
AST-OPC1
CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
It’s always great to start the week off with some good news. Today we learned that the Food and Drug Administration (FDA) has given Asterias Biotherapeutics approval to expand the number and type of people with spinal cord injuries that it treats in their CIRM-funded clinical trial. Up till now, Asterias has been treating people … Continue reading CIRM-funded stem cell clinical trial for spinal cord injury expands patient recruitment
Good news from Asterias’ CIRM-funded spinal cord injury trial
This week in the stem cell field, all eyes are on Asterias Biotherapeutics, a California-based company that’s testing a stem cell based-therapy in a CIRM-funded clinical trial for spinal cord injury patients. The company launched its Phase 1/2a clinical trial back in 2014 with the goal of determining the safety of the therapy and the … Continue reading Good news from Asterias’ CIRM-funded spinal cord injury trial
First spinal cord injury trial patient gets maximum stem cell dose
There comes a pivotal point in every experiment where you say “ok, now we are going to see if this really works.” We may be at that point in the clinical trial we are funding to see if stem cells can help people with spinal cord injuries. Today Asterias Biotherapeutics announced they have given the … Continue reading First spinal cord injury trial patient gets maximum stem cell dose
The Stem Cellar 